Deciphex, an innovator in Pathology AI, announces the strategic appointment of Dr. Pierre Moulin as Chief Scientific Officer.  Dr Moulin, MD, PhD, MBA has established himself as a distinguished physician-scientist and pathologist, with...

From LinkedIn: Congratulations to the entire Deciphex team on our double win at the Irish Medtech Awards! 🎉 We're absolutely thrilled to have been named Medtech Company of the Year and to receive the Digital Health Innovation of the Year...

PRINCETON, NJ and DUBLIN, IRELAND / ACCESSWIRE / September 14, 2023 / Deciphex, a trailblazer in digitizing and networking global pathologists, has joined forces with Xybion, a global leader in unified cloud software solutions for regulated...

Exeter, 24th August 2023 – Deciphex, a pioneering leader in digital pathology solutions, is pleased to announce the acceptance of, Diagnexia UK Limited, into the Medicines and Healthcare products Regulatory Agency (MHRA) GLP Monitoring...

Exeter, England, April 19th 2023 — Diagnexia UK Limited, owned by Deciphex, is the UK's fastest-growing pathology diagnostics service provider. Today, the company proudly celebrated the launch of its expanded facility at Exeter Science Park....

DUBLIN, Ireland, January 25th 2023 — Deciphex, a leading provider of pathology software and services, announced today a further €3.9m in funding bringing its full Series B round tally to €14.4m. The additional investment, led by Seroba...